Rockwell Medical Inc (RMTI): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Rockwell Medical ( RMTI) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.7%. By the end of trading, Rockwell Medical fell $0.29 (-1.9%) to $15.30 on light volume. Throughout the day, 935,928 shares of Rockwell Medical exchanged hands as compared to its average daily volume of 2,620,700 shares. The stock ranged in price between $15.00-$15.85 after having opened the day at $15.59 as compared to the previous trading day's close of $15.59. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 38.6%, CombiMatrix Corporation ( CBMX), down 14.1%, Conatus Pharmaceuticals ( CNAT), down 11.9% and Amarin Corporation ( AMRN), down 11.5%.

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. Rockwell Medical has a market cap of $600.0 million and is part of the drugs industry. Shares are up 86.3% year to date as of the close of trading on Thursday. Currently there are 2 analysts that rate Rockwell Medical a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Rockwell Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins, weak operating cash flow and generally higher debt management risk.

On the positive front, Ariad Pharmaceuticals ( ARIA), up 35.5%, Galena Biopharma ( GALE), up 14.6%, POZEN ( POZN), up 14.6% and Cardiome Pharma Corporation ( CRME), up 14.4% , were all gainers within the health care sector with Regeneron Pharmaceuticals ( REGN) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Stocks Rise, Facebook Ignites a Nasdaq Rally

Stocks Rise, Facebook Ignites a Nasdaq Rally

Short Seller Chanos Slams Tesla's Musk, Accuses Him of 'Incinerating' Capital

Short Seller Chanos Slams Tesla's Musk, Accuses Him of 'Incinerating' Capital

AMD Shares Explode After Solid Q1, Robust Outlook That Defies Chip Sector Gloom

AMD Shares Explode After Solid Q1, Robust Outlook That Defies Chip Sector Gloom

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts